Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806038 · ClinicalTrials.gov registry record · NA
Drug-Related Problems and Healthcare Utilization Post-Hospital Discharge
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01806038: Completed NA study, sponsored by Duke University.
NCT01806038 is a NA study that has completed, run by Duke University. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01806038, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of this study is to investigate whether pharmacist provided counseling and medication dispensing at the patient's bedside can provide better outcomes than the current discharge process at Duke University Hospital. This study will be single-site, prospective, randomized, cohort study. Patients who meet the inclusion and exclusion criteria, and provide consent will be included in this study.
Interventions
- OTHER RPh Counseling + Outpatient Med Dispensing at Discharge
- OTHER Discharge Med Dispensing Plus Counseling - Current Practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01806038 record still lists
NCT01806038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which RPh Counseling + Outpatient Med Dispensing at Discharge is the first listed.
NCT01806038 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01806038 about?
NCT01806038 is a clinical study titled "Drug-Related Problems and Healthcare Utilization Post-Hospital Discharge". The goal of this study is to investigate whether pharmacist provided counseling and medication dispensing at the patient's bedside can provide better outcomes than the current discharge process at Duke University Hospital. This study will be single-site, prospective, randomized, cohort study. Patien...
What is the current status of trial NCT01806038?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2013-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01806038?
The interventions under investigation include: RPh Counseling + Outpatient Med Dispensing at Discharge (OTHER), Discharge Med Dispensing Plus Counseling - Current Practice (OTHER).
Who is sponsoring clinical trial NCT01806038?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01806038's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia